Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and NeckWaun Ki Hong, Helmuth Goepfert, S. M. Lippman et al.|New England Journal of Medicine|1990Cited by 1.4k
Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationshipsHoward D. Thames, Gilbert H. Fletcher, H. Rodney Withers et al.|International Journal of Radiation Oncology*Biology*Physics|1982Cited by 842
Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02Lester J. Peters, Danny Rischin, Brian O’Sullivan et al.|Journal of Clinical Oncology|2010Cited by 806
Prognostic Significance of p16 <sup>INK4A</sup> and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III TrialDanny Rischin, Grant A. McArthur, Richard J. Young et al.|Journal of Clinical Oncology|2010Cited by 741
Prognostic Significance of [<sup>18</sup>F]-Misonidazole Positron Emission Tomography–Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer Randomly Assigned to Chemoradiation With or Without Tirapazamine: A Substudy of Trans-Tasman Radiation Oncology Group Study 98.02Danny Rischin, Lester J. Peters, Rodney J. Hicks et al.|Journal of Clinical Oncology|2006Cited by 543